The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Zollinger-Ellison syndrome is characterized by excessive gastric acid secretion.
• Effective management of gastric acid hypersecretion is crucial for patient outcomes.

Observation:

• Metiamide, an H2-receptor antagonist, was administered to three Zollinger-Ellison syndrome patients.
• Acid secretion was inhibited by 85-100% for 2.5 hours with metiamide alone.

Findings:

• Combining metiamide with anticholinergic drugs significantly prolonged the acid-inhibitory effect.
• Patients experienced relief from ulcer pain and diarrhea, with weight gain during treatment.

Implications:

• H2-receptor antagonists, particularly in combination therapy, show promise for managing Zollinger-Ellison syndrome.
• This approach may offer an alternative for patients unable to undergo or refusing surgery.